Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 10, 2015
Patent Application Number
14212057
Date Filed
March 14, 2014
Patent Citations Received
Patent Primary Examiner
Patent abstract
Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds described herein are useful for inhibiting PRMT1 activity. Methods of using the compounds for treating PRMT1-mediated disorders are also described.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.